AJANTA PHARMA LTD - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

Ajanta Pharma Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

Download	< Back
24 Mar 2025
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 24, 2025 for Ravi Agrawal, trustee Ravi Agrawal Trust
View all announcements for Ajanta Pharma Ltd	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2025	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us

ALL MONEYWIZ PAGES